AbbVie Inc., enticed in part by a $50.8 million incentive package, has chosen North Carolina for construction of a $1.4 ...

The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...

These companies offer a clear path to sustained earnings growth.

When it comes to small modular reactors, there is a gulf between concept and proof. And until proven, caution and skepticism ...

Trump has touted his program for lower drug prices as “tremendous savings” for people on Medicare. Lowering the cost of ...

Investors who fixate solely on share price overlook this distinction. Said differently, a $50 stock with stagnant earnings ...

Parkland School Board members expressed deep skepticism about a proposed tax break for Eli Lilly, using their Tuesday ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

Following the US Food and Drug Administration approval of Foundayo on April 1 for chronic weight management, Eli Lilly is ...

When the New York Times recently posted a fluffy profile of billionaire socialite Lauren Sánchez Bezos, Katie Couric couldn’t ...

The acquisition of Kelonia Therapeutics, announced this week, is part of Lilly’s expansion into cancer treatments.